Genmab — Januar 2018
-
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment - https://link.springer.com/article/10.1007%2Fs13317-017-0100-y
-
They look identical on clinicaltrials https://clinicaltrials.gov/ct2/show/NCT02792218?term=ASCLEPIOS&rank=1 https://clinicaltrials.gov/ct2/show/NCT02792231?term=ASCLEPIOS&rank=2
-
-
-
E L: It's the toughest scientific claim: randomized, double-blind/double-dummy, active-controlled, multi-center trials of identical design conducted in parallel. http://n.neurology.org/content/88/16_Supplement/S16.005
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind